دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 1 نویسندگان: W. G. Robertson, M. Peacock, D. Ouimet, P. J. Heyburn, A. Rutherford (auth.), Lynwood H. Smith, William G. Robertson, Birdwell Finlayson (eds.) سری: ISBN (شابک) : 9781468489798, 9781468489774 ناشر: Springer US سال نشر: 1981 تعداد صفحات: 974 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 21 مگابایت
کلمات کلیدی مربوط به کتاب Urolithiasis: تحقیقات بالینی و اساسی: نفرولوژی
در صورت تبدیل فایل کتاب Urolithiasis: Clinical and Basic Research به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب Urolithiasis: تحقیقات بالینی و اساسی نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
در سال 1968 Dr. B. E. C. Nordin و A. Hodgkinson اولین سمپوزیوم بین المللی تحقیقات سنگ کلیه را در لیدز، انگلستان ترتیب دادند. صد و پنج شرکتکننده از اروپای قارهای، بریتانیای کبیر و ایالات متحده برای بررسی کار خود و تبادل نظر در مورد تشکیل سنگهای ادراری گرد هم آمدند. این نشست به چند هدف مهم دست یافت. گروهی از کارگران در بسیاری از رشته های علمی مرتبط با سنگ کلیه را گرد هم آورد. این نیدوس به عنوان بذر رشد تحقیقاتی در یک زمینه پیچیده و میان رشته ای عمل کرد. این انجمن یک انجمن برای ادامه ارتباط در تحقیقات سنگهای ادراری با سمپوزیای بعدی که هر 4 سال یک بار برگزار میشود، ایجاد کرد. سمپوزیوم ویلیامزبورگ چهارمین سمپوزیوم از مجموعه داووس لیدز-مادرید بود که شامل 186 شرکت کننده از سراسر جهان بود. تاکید بر تحقیقات بالینی در حال انجام در این زمینه بود. هیچ سخنران دعوت شده ای وجود نداشت و برای اولین بار 41 مقاله که به صورت شفاهی در جلسه ارائه شد از بین 184 چکیده ارسالی انتخاب شدند. در مجموع 134 مقاله در جلسات پوستر در بعدازظهرها ارائه شد که در آن تبادل غیر رسمی بین شرکت کنندگان علاقه مند و محققین بدون محدودیت جلسه عمومی امکان پذیر بود. تقریباً تمام زمینههای تحقیقات سنگهای ادراری از بنیادیترین شیمی فیزیکی گرفته تا الگوهای بالینی بیماری و روشهای خاص درمان در این جلسه ارائه، بررسی و بحث شد.
In 1968 Drs. B. E. C. Nordin and A. Hodgkinson organized the First International Symposium on Urolithiasis Research in Leeds, England. One hundred and five participants from continental Europe, Great Britain, and the United States met to review their work and exchange ideas regarding the formation of urinary calculi. This meeting achieved several important goals. It pulled together a nidus of workers in the many scientific disciplines that relate to urolithiasis. This nidus served as the seed for research growth in a complex, interdisciplinary field. It established a forum for con tinuing communication in urolithiasis research with subsequent sym posia being held every 4 years. The Williamsburg Symposium was the fourth in the Leeds-Madrid Davos series involving 186 participants from throughout the world. A stated emphasis was on clinical research under way in the field. There were no invited speakers and for the first time the 41 papers that were presented orally at the meeting were selected from 184 submitted abstracts. A total of 134 papers were presented in the poster sessions in the afternoons where informal exchange between interested participants and investigators could occur without the restrictions of a plenary session. Virtually all areas of urolithi asis research from the most fundamental physical chemistry to clinical patterns of disease and specific modes of treatment were presented, reviewed and discussed during the meeting.
Front Matter....Pages i-xxvi
Front Matter....Pages 1-1
The Main Risk Factor for Calcium Oxalate Stone Disease in Man: Hypercalciuria or Mild Hyperoxaluria?....Pages 3-12
Prediction of Stone Recurrence....Pages 13-16
Crystalluria....Pages 17-21
Study of Calcium Crystals in Patients with Kidney Stones....Pages 23-27
Metabolic Investigations in 407 Recurrent Stone-Formers and Healthy Controls on Condition of Individual as well as Standard Diet....Pages 29-34
Classification of Stone-Patients and Healthy Persons on the Basis of the Urinary Analysis....Pages 35-38
Urinary Excretion of Citrate in Normal Subjects and Patients with Urolithiasis....Pages 39-44
Magnesium Excretion in Urine on Condition of Individual as well as Standard Diet in Healthy Controls and Calcium Oxalate Stone Formers....Pages 45-49
Circadian Excretion of Uric Acid on Condition of Standard Diet after Purine Load in Calcium Oxalate Stone-Formers and Healthy Controls....Pages 51-54
Hypophosphatemia in Recurrent Renal Stone Formers — Consequence of Arterial Hypertension?....Pages 55-59
Relationship of Urinary Calcium to Sodium Excretion in Calcareous Renal Stoneformers: Effect of Furosemide....Pages 61-65
The Clinical Importance of Renal Tubular Acidosis in Recurrent Renal Stone Formers....Pages 67-69
Experience with the Short Ammonium Chloride Test....Pages 71-76
Urinary Excretion of Amino Acids by Subjects with Renal Calculi....Pages 77-80
Excretion of the CA-Binding Amino Acid, γ-Carboxyglutamate, in Stone-Formers....Pages 81-88
Renal Stone Formation in Primary Hyperparathyroidism — Role of Tubular Dysfunction....Pages 89-92
Short Ammonium Chloride Loading Test for Evaluation of Hyperparathyroidism....Pages 93-97
Saturation of Urine in Primary Hyperparathyroidism: Its Role in Renal Stone Formation....Pages 99-102
Medullary Sponge Kidney (Tubular Ectasia) in Calcium Urolithiasis....Pages 105-112
Clinical and Laboratory Findings in Patients with Medullary Sponge Kidney....Pages 113-120
Front Matter....Pages 1-1
Hereditary Hyperuricosuric Urolithiasis....Pages 121-124
2, 8-Dihydroxyadeninuria: Or When is a Uric Acid Stone not a Uric Acid Stone?....Pages 125-130
Renal Calculi in Triamterene Users....Pages 131-137
Cystine Stone — Therapy with Alpha-Mercapto-Propionylglycine — Ten Years of Experience with Forty-Two Patients....Pages 139-143
The Natural History of Cystinuria: A 15 Year Follow-Up in 106 Patients....Pages 145-154
Glutamine Therapy of Cystinuria....Pages 155-157
Urinary Stone Formation in Bowel Disease....Pages 159-168
Prevalence of Nephrolithiasis in Malabsorptive Syndromes....Pages 169-172
The Influence of Gastrointestinal Anatomy on Oxalate Excretion and Kidney Stone Incidence in Patients with Enteric Hyperoxaluria....Pages 173-177
Therapy for Enteric Hyperoxaluria: A Comparison of Calcium Supplementation and Urinary Alkalinization....Pages 179-190
Retrospective Follow-Up of Patients with Struvite Calculi....Pages 191-193
Infected Renal Lithiasis: Results of Long-Term Surgical and Medical Management....Pages 195-198
Infection-Induced Stones: Status of Clinic Trials with Urostat™ (Acetohydroxamic Acid)....Pages 199-208
Urease Inhibitors in the Treatment of Infection Induced Stones: Some Chemical, Pharmacologic and Clinical Considerations....Pages 209-214
Complications and Management of “Neglected” Renal Stones....Pages 215-220
Field Preventive Program of Bladder Stone Disease in Thailand....Pages 221-224
Objective Evidence for the Beneficial Effect of a High Fluid Intake in the Management of Nephrolithiasis....Pages 227-233
Reduction of Urinary Oxalate Excretion during Chronic Thiazide Therapy....Pages 235-239
Long-Term Treatment with Bendroflumethiazide for Prevention of Renal Stones. Clinical Experiences....Pages 241-244
Long-term Treatment with Bendroflumethiazide for Prevention of Stones. Metabolic Effects....Pages 245-248
Front Matter....Pages 1-1
Experiences with Thiazides in a Double Blind Study....Pages 249-252
Neutral Potassium Phosphate and Thiazide: Combined Treatment in Recurrent Stone Formers....Pages 253-258
Phosphate Treatment of Idiopathic Calcium Stone Disease....Pages 259-265
Prophylactic Treatment with Magnesium Hydroxide in Renal Stone Disease....Pages 267-273
Experiences with Long-Term Use of Sodium Cellulose Phosphate for Prevention of Renal Calcium Stones....Pages 275-282
Long-Term Effects of Campanyl in the Treatment of Patients with Recurrent Calcium Urinary Stones....Pages 283-286
How to Increase the Lithoprotective and/or Litholytic Properties of Urine....Pages 287-292
Natural Volatile Oils in the Management of Renal Calcium Stone Disease....Pages 293-296
Fybranta (R) — A New Approach to the Treatment of Idiopathic Hypercalciuria....Pages 297-300
Front Matter....Pages 301-301
A Risk Factor Model of Stone-Formation: Application to the Study of Epidemiological Factors in the Genesis of Calcium Stones....Pages 303-307
The Role of Affluence in Recurrent Stone Formation....Pages 309-313
Alcohol as an Epidemiological Risk in Urolithiasis....Pages 315-319
Familial Hypercalciuric Urolithiasis....Pages 321-323
Cause of Primary Bladder Stone in England — A Retrospective Epidemiological Study....Pages 325-328
Endemic Bladder Stones in Indonesia....Pages 329-332
Future of Tamarind and Tartrate in Preventing Recurrence of Renal Calculi....Pages 333-336
Dietary Structure and Urinary Composition in a Stone-Free Population....Pages 337-342
Idiopathic Hypercalciuria — Its Control with Unprocessed Bran....Pages 343-346
Urolithiasis — A Study of Drinking Water Hardness and Genetic Factors....Pages 347-348
Urine Chemistry in Renal Stone Formers in an Area with Soft Drinking Water....Pages 349-352
Front Matter....Pages 301-301
The Importance of Chronic Cadmium Poisoning in Renal Stone Formation — A Five Year Study....Pages 353-357
Should Recurrent Calcium Oxalate Stone Formers Eat Less Animal Protein?....Pages 359-362
Influence of Purine Content of Diet and Allopurinol on Uric Acid and Oxalate Excretion Levels....Pages 363-367
Increased Availability of Dietary Carbohydrate: A Factor in the Genesis of Idiopathic Calcium Oxalate Urolithiasis?....Pages 369-372
Reduction of Urinary Oxalate Excretion in Primary Hyperoxaluria by Diet....Pages 373-377
Front Matter....Pages 379-379
Preface to Proposal of Standardized Nomenclature in the Study of Crystallization in Biological Systems....Pages 381-381
A Proposal of Standardized Nomenclature in the Study of Crystallization in Biological Systems, e.g. Urolithiasis....Pages 383-390
A Constant Composition Method for Modelling Urinary Stone Formation....Pages 391-399
Crystal Growth and Aggregation of Calcium Oxalate in High Ionic Strength Solutions....Pages 401-409
The Electrical Double Layer at Calcium Oxalate-Water Interfaces....Pages 411-419
Calcium Electrode Measurements of Calcium Oxalate Mineralization: The Effects of Urine and other Inhibitors....Pages 421-425
Effect of Urinary Macromolecules on Calcium Oxalate Dihydrate Crystal Growth and Nucleation Rates....Pages 427-436
Equilibrium-Based Computer Model for the Estimation of Urine Saturation....Pages 437-440
The Relation between Relative Supersaturation and Crystal Aggregation in Urine — An Sem Study and a Computerized Calculation of the Ion Equilibrium....Pages 441-445
Determination of the Stability Constant of the Calcium Dioxalate Complex....Pages 447-451
Calcium Oxalate Hydrates. Dissolution, Transformation and Crystallization Studies....Pages 453-457
On the Transition Amorphous Calcium Phosphate to Crystalline Octacalcium Phosphate....Pages 459-464
Stabilizing Factors for Uric Acid Dihydrate — A Contribution to Uric Acid Stone Formation....Pages 465-468
Epitaxis between Stone-Forming Crystals at the Atomic Level....Pages 469-480
The Effect of Seed Crystals on Calcium Oxalate Nucleation....Pages 481-488
Front Matter....Pages 379-379
The Effect of Urinary pH on the Saturation of Calcium and Oxalate and on Urinary Crystal Formation....Pages 489-492
Hyperuricosuria in Calcium Oxalate Urolithiasis and its Possible Relationships with Stone Matrix Formation....Pages 493-496
Calcium Oxalate Crystallization in Urothelial-Lined Systems....Pages 497-508
Intrarenal Calcium and Oxalate Concentration Gradients in Healthy and Stone Forming Kidneys — The Renal Papilla as the Primary Nucleation Site....Pages 509-515
Rat Renal Papillary Structure in Oxalate-Induced Microlithiasis, A Scanning Electron Microscope Study....Pages 517-521
The Ultrastructure of Rat Renal Tubules in Experimental Calcium Oxalate Nephrolithiasis....Pages 523-525
Crystal Formation in the Renal Tubules of Rats Induced by Ethylene Glycol Administration and Magnesium Deficiency....Pages 527-532
A New View of Stone Formation under the Aspect of Flow Dynamics....Pages 533-537
Rates and Mechanisms of Dissolution of Renal Calculi. I. Rates and Mechanism of Dissolution of Pure Calcium Oxalate Monohydrate in Acid and Edta Solution....Pages 539-544
Rates and Mechanisms of Dissolution of Renal Calculi. II. Development and Discussion of Potential Models for Dissolution of Oxalate Calculi....Pages 545-549
Rates and Mechanisms of Dissolution of Renal Calculi. III. Mechanisms and Rates of Dissolution of Simulated Oxalate Calculi in Acid and Edta Solutions....Pages 551-556
Front Matter....Pages 557-557
Inhibition of PTH-Induced Nephrocalcinosis by Phosphocitrate....Pages 559-568
The Sources of Phosphocitrate and its Role as an Inhibitor of Calcium Phosphate and Calcium Oxalate Crystallization....Pages 569-577
Characterization of the Calcium Oxalate Crystal Growth Inhibitors in Human Urine....Pages 579-588
Inhibitors of Calcium Oxalate and Calcium Phosphate Crystal Formation in Urine — A Critique and Reappraisal....Pages 589-599
Studies on Inhibitors and Promoters of the Crystallization of Calcium Oxalate in Urine and in Matrix from Calcium Oxalate Stones....Pages 601-605
Effect of Different Urinary Constituents on Inhibiting or Accelerating Calcium Oxalate Crystallization....Pages 607-610
The Effect of Normal and Stone-Forming Urine on the Growth and Aggregation of Calcium Oxalate Crystals in Relation to Urinary Glycosaminoglycan and Urate Concentrations....Pages 611-618
Urinary Glycosaminoglycan Excretion in Patients with Urolithiasis....Pages 619-622
Inhibition of Calcium Oxalate Crystal Growth in Patients with Urolithiasis....Pages 623-629
Front Matter....Pages 557-557
The Effect of Urine and Other Inhibitors on the Growth and Aggregation of Calcium Oxalate Crystals in Vitro....Pages 631-635
Identification of a Small Molecular Weight Inhibitor of the Oxalate Precipitation....Pages 637-639
The Effect of Some Urinary Constituents on the in Vitro Nucleation and Growth Kinetics of Calcium Oxalate....Pages 641-650
Isolation of a Urinary Mucoprotein Capable to Precipitate Oxalate....Pages 651-655
The Inhibitory Effect of Polymeric Carboxylic Amino-Acids and Urine on Calcium Oxalate Crystallization....Pages 657-662
Inhibited Precipitation and Growth of Ca-Oxalate Crystals in the Presence of the Alkaline Salts of Some Polyhydroxycarboxylic Acids....Pages 663-667
Interaction of Dyes with Inorganic Constituents of Kidney Stones....Pages 669-672
Front Matter....Pages 673-673
Urinary Calcium Binding Proteins and Renal Calculi....Pages 675-684
Excretion of Tamm-Horsfall Urinary Glycoprotein (Uromucoid) in Renal Calcium Stone Formers....Pages 685-689
Proteolytic Activity and Organic Substances in Urine....Pages 691-695
Mechanism of the Heterogeneous Nucleation by a Urinary Mucoprotein....Pages 697-701
Nephrolithiasis in Dialysed Patients — Evidence for a Peculiar Type of Matrix Stones with Ca-Oxalate Inclusions....Pages 703-706
The Chemical Composition of a Non-Crystalline Feline Kidney Stone....Pages 707-711
Front Matter....Pages 713-713
The Effects of Chlorothiazide on Sodium, Calcium, and Magnesium Transport in the Nephron of the Thyroparathyroidectomized Hamster....Pages 715-721
Indomethacin Lowers Urinary Calcium Excretion in Normal Volunteers and Normocalciuric Stone-Formers....Pages 723-725
On the Mechanism of Action of 1,25(OH) 2 D 3 in the Intestine....Pages 727-730
Low Phosphate Diet in Rats: A Model for Calcium Oxalate Urolithiasis....Pages 731-734
Intracellular Mechanisms Underlying the Phosphaturic Response to Parathyroid Hormone in the Hamster....Pages 735-740
Role of Nicotinamide Adenine Dinucleotide (NAD) in Control of Proximal Renal Tubular Phosphate Transport....Pages 741-745
The Incidence of Nephrocalcinosis and the Urinary Excretion of Citrate and Calcium in Patients with Non-Azotemic type 4 Renal Tubular Acidosis....Pages 747-755
Front Matter....Pages 713-713
Urinary Citrate Excretion and Acidification Defects in Renal Calcium Stone Formers....Pages 757-761
Influence of Changes in Calcium Metabolism on Renal Handling of Oxalate in Rats....Pages 763-766
Evaluation of a New Oxalate Assay....Pages 767-773
Intestinal Oxalate Absorption in Calcium Oxalate Stone Disease....Pages 775-778
Oxalate Loading Test for the Diagnosis of Oxalate Hyperabsorption....Pages 779-781
Effect of Vitamin B 6 Deficiency on the Intestinal Absorption and Excretion of Oxalate in Rats....Pages 783-787
Excretion of Oxalic Acid Following the Ingestion of Various Amounts of Oxalic Acid-Rich Foods....Pages 789-794
Response of Gastrointestinal Hormones and Intestinal Calcium Absorption During an Oral Carbohydrate Meal....Pages 795-800
How to Prevent the Hyperresorption of Dietary Oxalate and the Oxalate Peaks in Urine....Pages 801-805
Isolation of the Oxalate Binding Protein....Pages 807-810
Front Matter....Pages 811-811
The Pathophysiological Basis of Hypercalciuria in Primary Hyperparathyroidism....Pages 813-824
Plasma 1,25(OH) 2 D in Idiopathic and Hyperparathyroid Stone-Formers....Pages 825-829
Orthophosphate Therapy Decreases Urinary Calcium Excretion and Serum 1,25-Dihydroxy Vitamin D Concentrations in Idiopathic Hypercalciuria....Pages 831-833
Cyclic Nucleotides and Related Variables in Urolithiasis....Pages 835-840
Disturbed Terminal Mineralization of Bone in Idiopathic Hypercalciuria....Pages 841-845
Dietary Calcium Restriction may be Good for Patients’ Stones — but not for Their Bones....Pages 847-854
The Pathways of Oxalate Biosynthesis....Pages 855-863
Alterations in Kidney Enzymes of Oxalate Metabolism in Patients with Urolithiasis....Pages 865-868
Therapeutic Role of Vitamin B 6 on Oxalate Metabolism in Urolithiasis and its Effect on Hyperoxaluria Induced in Rats by Ethylene Glycol....Pages 869-873
Decomposition of Exogenous 14 C-Oxalate ( 14 C-OX) to 14 C-Carbon Dioxide ( 14 CO 2 ) In Vitro and in Animals....Pages 875-879
Front Matter....Pages 811-811
Enhancement of Urinary Citrate in Oxalate Stone Formers by the Intake of Alkaline Salts....Pages 881-884
Magnesium Metabolism in Renal Stone Formers....Pages 885-887
Urate Metabolism and Urinary Acidification....Pages 889-893
Urate Metabolism in Calcium Stone Disease....Pages 895-898
Front Matter....Pages 899-899
Investigation with Polarizing Microscopy for the Classification of Urinary Stones from Humans and Dogs....Pages 901-906
Statistical Results of the Analysis of More than 7,500 Urinary Calculi....Pages 907-909
“Milk of Calcium”: Morphology, Structure and Mineralogical Composition....Pages 911-915
Oolitic Structure of Milk of Calcium Sand and Milk of Calcium Stones....Pages 917-921
Silica in Urinary Calculi....Pages 923-927
Newberyte in Old Renal and Bladder Calculi....Pages 929-934
Forms of Ammonium Urate Presentation in Urinary Calculi of Non-Infectious and Infectious Origin....Pages 935-942
Prostatic Calculi....Pages 943-948
Front Matter....Pages 949-949
Isotachophoretic Determination of Oxalate in Unprocessed Urine....Pages 951-957
Analytical Isotachophoresis: An Improved Method for Quantitative Determination of Urinary Oxalate....Pages 959-962
The Effect of Storage on Serum Oxalate Values....Pages 963-967
Direct Measurement of Ionized Calcium (Standardization, Normal Values and Clinical Results)....Pages 969-976
New Glass Capillary Gas-Chromatographic Methods for Metabolites in Urine and Serum....Pages 977-983
Comparison of X-Ray Diffraction, IR-Spectroscopic, and Polarizing Microscopic Core-Shell Analysis of Urinary Stones....Pages 985-991
Experience with infrared Analysis of Urinary Tract Calculi in a Clinical Laboratory....Pages 993-996
High Voltage Electron Microscopy of Urinary Calculi....Pages 997-1001
Front Matter....Pages 949-949
Physical Investigations of Urinary Calculi....Pages 1003-1008
Investigations for Characterizing Single Crystal Phases in Urinary Stones by Means of an Arrangement of Light Microscopy in Combination with Scanning Microscopy....Pages 1009-1013
Back Matter....Pages 1015-1035